检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
作 者:杨雪 王哲芸[1] 康玉贝 刘丽娟 王岩 YANG Xue;WANG Zhe-Yun;KANG Yu-Bei(Department of Cardiology,Nanjing Drum Tower Hospital,the Affiliated Hospital of Nanjing University Medical School,Nanjing 210008,Jiangsu,China)
机构地区:[1]南京大学医学院附属鼓楼医院心外科,江苏南京210008
出 处:《吉林医学》2025年第1期201-205,共5页Jilin Medical Journal
基 金:南京鼓楼医院2022年度护理科研课题项目[项目编号:2022-B895]。
摘 要:目的:分析Gordon模式个案管理对老年心脏瓣膜病术后患者抗凝药物用药依从性及自我效能的影响。方法:选取200例于南京大学医学院附属鼓楼医院2022年1月~12月进行治疗的老年心脏瓣膜病术后患者,随机分为对照组和观察组各100例。对照组使用常规护理,观察组在对照组基础上使用Gordon模式个案管理,观察两组患者抗凝药物用药依从性、自我效能、生活质量、抗逆力情况。结果:干预后两组患者抗凝药物用药依从性、自我效能、生活质量、抗逆力等相关指标评分均高于对照组,差异有统计学意义(P<0.05)。结论:对老年心脏瓣膜病术后患者进行Gordon模式个案管理干预,可有效提高患者抗凝药物用药依从性及自我效能。Objective To analyze the impact of Gordon model case management on the adherence and self-efficacy of anticoagulant medication in elderly patients after heart valve disease surgery.Method 200 elderly patients with postoperative heart valve disease who underwent treatment in our hospital from January 2022 to December 2022 were selected and divided into a control group and an observation group,with 100 cases in each group.The control group received routine care,while the observation group received Gordon mode case management on the basis of the control group.The compliance,self-efficacy,quality of life,and resistance to anticoagulant medication in two groups of patients were observed.Results After intervention,the scores of anticoagulant medication adherence,self-efficacy,quality of life,and resistance in both groups of patients were higher than those in the control group(P<0.05).Conclusion Gordon model case management intervention for elderly patients with postoperative heart valve disease can effectively improve their adherence to anticoagulant medication and self-efficacy.
关 键 词:老年心脏瓣膜病 Gordon模式个案管理 抗凝药物用药依从性 自我效能
分 类 号:R542.5[医药卫生—心血管疾病]
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:3.149.249.140